Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.35
-0.16-10.60%
At close: May 14, 5:00 PM EST
$1.45
-0.06-3.97%
Pre-Market: 8:30 AM EST
Allarity Therapeutics Inc Analyst Ratings
ALLRNASDAQ
Earnings: Q1 2026 Earnings were released on Fri May 15th, after the market close
Allarity Therapeutics Analyst Ratings and Price Targets | NASDAQ:ALLR | Benzinga
Allarity Therapeutics Inc has a consensus price target of $9.75 based on the ratings of 1 analysts. The high is $9.75 issued by Ascendiant Capital on April 10, 2026. The low is $9.75 issued by Ascendiant Capital on April 10, 2026. The 3 most-recent analyst ratings were released by Ascendiant Capital on April 10, 2026, December 9, 2025, and September 26, 2025, respectively. With an average price target of $9.5 between Ascendiant Capital, there's an implied 555.17% upside for Allarity Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
1calculated from analyst ratings
Analyst Ratings for Allarity Therapeutics
Loading calendar...
FAQ
What is the target price for Allarity Therapeutics (ALLR) stock?
The latest price target for Allarity Therapeutics (NASDAQ:ALLR) was reported by Ascendiant Capital on April 10, 2026. The analyst firm set a price target for $9.75 expecting ALLR to rise to within 12 months (a possible 572.41% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Allarity Therapeutics (ALLR)?
The latest analyst rating for Allarity Therapeutics (NASDAQ:ALLR) was provided by Ascendiant Capital, and Allarity Therapeutics maintained their buy rating.
When was the last upgrade for Allarity Therapeutics (ALLR)?
There is no last upgrade for Allarity Therapeutics
When was the last downgrade for Allarity Therapeutics (ALLR)?
There is no last downgrade for Allarity Therapeutics.
When is the next analyst rating going to be posted or updated for Allarity Therapeutics (ALLR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allarity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allarity Therapeutics was filed on April 10, 2026 so you should expect the next rating to be made available sometime around April 10, 2027.
Is the Analyst Rating Allarity Therapeutics (ALLR) correct?
While ratings are subjective and will change, the latest Allarity Therapeutics (ALLR) rating was a maintained with a price target of $9.50 to $9.75. The current price Allarity Therapeutics (ALLR) is trading at is $1.45, which is out of the analyst’s predicted range.
